ArticleFrontiers in oncology2022

Immune Checkpoint Inhibitor-Based Systemic Therapy Shows Remarkable Curative Effect in a Hepatocellular Carcinoma Patient With Intractable Postoperative Recurrence and Metastases: A Case Report and Literature Review.

Xing He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.